Global Liver Biopsy Market Growth (Status and Outlook) 2023-2029

Global Liver Biopsy Market Growth (Status and Outlook) 2023-2029

Liver biopsy is the biopsy (removal of a small sample of tissue) from the liver. It is a medical test that is done to aid diagnosis of liver disease, to assess the severity of known liver disease, and to monitor the progress of treatment.

LPI (LP Information)' newest research report, the “Liver Biopsy Industry Forecast” looks at past sales and reviews total world Liver Biopsy sales in 2022, providing a comprehensive analysis by region and market sector of projected Liver Biopsy sales for 2023 through 2029. With Liver Biopsy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Liver Biopsy industry.

This Insight Report provides a comprehensive analysis of the global Liver Biopsy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Liver Biopsy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Liver Biopsy market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Liver Biopsy and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Liver Biopsy.

The global Liver Biopsy market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

Liver biopsies may be taken percutaneously (via a needle through the skin), transvenously (through the blood vessels), endoscopically (through endoscopic ultrasound fine needle biopsy), or directly during abdominal surgery. The sample is examined by microscope, and may be processed further by immunohistochemistry, determination of iron and copper content, and microbiological culture if tuberculosis is suspected.

This report presents a comprehensive overview, market shares, and growth opportunities of Liver Biopsy market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Percutaneous
Transjugular
Laparoscopic

Segmentation by application
Hospitals & Clinics
Diagnostic Centers
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Cook Medical
Boston Scientific
Hologic
MDxHealth
CR Bard
Intact Medical
Veran Medical
Leica Biosystems

Please note: The report will take approximately 2 business days to prepare and deliver.